Top UK finreg lawyer talks regulation, risk, politics, crypto, when to shut up, and when to sing like a canary ...

Guidance for Q3 2025 revenue ($31 million to $34 million) is consistent with the previous quarter’s Q2 guidance. Management shifted toward highlighting operational breakeven and margin improvement, ...

Learn how to tell if your business could be facing a cash crunch ...

Strategic focus continues to be on Anaphylm’s FDA approval, commercial launch, and financing. Management reiterated international expansion plans for Anaphylm, whereas the previous quarter emphasized ...